# Non-OpeRative MANagement of Rectal Cancer Patients

> **NCT04696757** · PHASE2 · COMPLETED · sponsor: **Kangbuk Samsung Hospital** · enrollment: 18 (actual)

## Conditions studied

- Rectal Cancer
- Chemoradiotherapy
- Watch & Wait

## Interventions

- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT04696757
- **Lead sponsor:** Kangbuk Samsung Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04696757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04696757, "Non-OpeRative MANagement of Rectal Cancer Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04696757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*